
EBIX Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
EBIX CMP Rs.26. Market cap Rs.564 Cr. PE Not meaningful. 12-month target Rs.26-29.
Updated: 9 Jul 2026 • 1:30 pm
Posted by:

EBIX Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with EBIX shares trading at Rs.26 against a market capitalisation of Rs.564 Cr and a price-to-earnings multiple of Not meaningful. As an IT services name on the NSE and BSE, EBIX enters the EBIX Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.
Quarterly financials for EBIX are not yet fully available on Univest’s data partners for this cycle; investors should track Screener.in and the NSE/BSE filings directly for the EBIX Q1 Results FY27 result date and cross-check any figures before making investment decisions.
Get Free Investment Predictions and EBIX Research at Univest
EBIX (NSE: EBIX) operates in the IT services space and is tracked on Univest under its NSE and BSE listings ahead of the EBIX Q1 Results FY27 season, forming the base against which the EBIX Q1 Results FY27 estimates in this article are built. This EBIX Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company’s own disclosures.
EBIX Q1 FY27 Estimates
| Metric | Detail |
|---|---|
| CMP | Rs.26 |
| Market Cap | Rs.564 Cr |
| Results Date | July-August 2026 (indicative) |
| 12-Month Target (Uniresearch Estimate) | Rs.26-29 |
Univest, a SEBI-Registered Investment Advisor, Tracks EBIX Ahead of Q1 FY27 Results
Key Catalysts to Watch
1. Deal Wins and Order Book
Deal wins and a healthy order book supporting revenue visibility for the quarter is one of the primary variables that analysts are tracking ahead of EBIX’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the EBIX share price target or faces renewed pressure.
2. Margin Management
Margin management through cost optimisation and utilisation improvement is one of the primary variables that analysts are tracking ahead of EBIX’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the EBIX share price target or faces renewed pressure.
3. Vertical Demand Recovery
Demand recovery in key verticals such as BFSI and healthcare supporting growth is one of the primary variables that analysts are tracking ahead of EBIX’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the EBIX share price target or faces renewed pressure.
Download the Univest iOS App or Univest Android App to track EBIX’s live price and Q1 FY27 result updates.
Key Risks to the EBIX Q1 Results FY27 Outlook
- Client budget deferrals or project delays in key verticals.
- Wage inflation and talent cost pressure affecting margins.
- Currency volatility impacting reported revenue growth.
Recent Performance Context
Detailed recent-quarter financials for EBIX were not available from Univest’s data partners at the time of writing. Investors should check Screener.in or the company’s exchange filings for the latest verified numbers before the Q1 FY27 results.
Technical Analysis Ahead of EBIX Q1 Results FY27
EBIX shares last traded at Rs.26. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.
Share Price Target Based on the EBIX Q1 Results FY27 Outlook
3-6 Month Target
Over a 3-6 month horizon, the EBIX Q1 Results FY27 trailing-growth framework points to a range of Rs.25-27 for EBIX, contingent on the EBIX Q1 Results FY27 print matching or beating the trailing growth trend.
12-Month Target
The 12-month target (Uniresearch estimate) tied to this EBIX Q1 Results FY27 view for EBIX works out to Rs.26-29, built on the same trailing revenue growth trend and current valuation multiple. Tracking is how Univest research categorises the stock heading into EBIX Q1 Results FY27, not a formal Buy or Sell call.
FY27-28 Outlook
Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this EBIX Q1 Results FY27 analysis would put EBIX in a Rs.27-32 range, though this is sensitive to sector-wide demand, cost trends and any change in the company’s competitive position.
What to Watch in the EBIX Q1 Results FY27 Print
- Revenue and PAT versus the EBIX Q1 Results FY27 estimate range in this preview.
- Management commentary on FY27 growth guidance and margin trajectory relevant to the EBIX Q1 Results FY27 narrative.
- Deal wins and a healthy order book supporting revenue visibility for the quarter
- Client budget deferrals or project delays in key verticals
Conclusion on EBIX Q1 Results FY27
EBIX enters the Q1 FY27 results season trading at Rs.26, with the 12-month Uniresearch target range of Rs.26-29 reflecting a tracking stance. Investors tracking the EBIX Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on EBIX Q1 Results FY27
When are EBIX Q1 FY27 results expected?
Ans. EBIX’s Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.
What is the EBIX Q1 FY27 revenue estimate?
Ans. Detailed quarterly estimates are not available for EBIX at this time; check Screener.in or the company’s exchange filings for verified numbers.
What is the EBIX share price target?
Ans. The 12-month Uniresearch estimate for EBIX share price target is Rs.26-29, based on trailing growth and current valuation multiples.
Is EBIX a good buy before Q1 FY27 results?
Ans. EBIX is tracking heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.
What should investors watch in EBIX’s Q1 FY27 results?
Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and deal wins and a healthy order book supporting revenue visibility for the quarter.
Where can I track EBIX share price live?
Ans. EBIX share price can be tracked live on the Univest app and website, along with research updates from SEBI-registered analysts.
Recent Articles

Intraday Stocks for Today: UltraTech Cement, ICICI Bank and HDFC Bank, Analyst Top Picks for 22 July 2026
22 July 2026

Sundaram Long Term Tax Advantage Fund Series IV vs Bank of India Mid Cap Tax Fund Series 1 Regular Growth: NAV, Returns and Maturity Status Compared
21 July 2026

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series IV: NAV, Returns and Maturity Status Compared
21 July 2026

Sundaram Long Term Tax Advantage Fund Series II vs SBI Series IV: NAV, Returns and Maturity Status Compared
21 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Intraday Stocks for Today: UltraTech Cement, ICICI Bank and HDFC Bank, Analyst Top Picks for 22 July 2026
Sundaram Long Term Tax Advantage Fund Series IV vs Bank of India Mid Cap Tax Fund Series 1 Regular Growth: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series III vs UTI Series IV: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series II vs SBI Series IV: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series III vs UTI Series VI: NAV, Returns and Maturity Status Compared
Popular this week
Intraday Stocks for Today: UltraTech Cement, ICICI Bank and HDFC Bank, Analyst Top Picks for 22 July 2026
Sundaram Long Term Tax Advantage Fund Series IV vs Bank of India Mid Cap Tax Fund Series 1 Regular Growth: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series III vs UTI Series IV: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series II vs SBI Series IV: NAV, Returns and Maturity Status Compared
Sundaram Long Term Tax Advantage Fund Series III vs UTI Series VI: NAV, Returns and Maturity Status Compared

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





